While promising, lipid-based formulations face several challenges:
Scalability and cost of production are significant hurdles in commercial development. Potential for premature drug leakage during storage or circulation. Need for precise characterization and quality control. Regulatory hurdles and lack of standardized protocols for clinical translation.
